Oklo is a nuclear technology company that is still years away from having a plant up and running, and it only booked its first-ever sales, a little over one million dollars, in the most recent quarter.
The company has about three billion dollars in the bank, which buys it time, but it is spending faster than it is bringing in new business, and it recently had to raise both its spending forecast and the number of shares it sells to investors to fund construction.
Today's stock price already assumes the company's first plant in Idaho starts running on its 2027 to 2028 target and that a real chunk of its long list of interested customers turns into paying contracts, which is a lot to count on in an industry with a long history of delays and cost overruns.
Overvalued, though not dramatically so.
A quick look at how a few well known investing styles might weigh this stock.
Investors who follow Cathie Wood's approach would frame Oklo as a bet on a disruptive shift in how power-hungry data centers get electricity, pointing to the roughly 12 gigawatts of framework agreements signed with Switch and Meta's own 1.2 gigawatt Ohio deal as evidence that huge future demand already exists. They would treat the still-unbuilt first reactor and zero revenue to date as the price of getting in before the technology is proven at scale.
A Chase Coleman-style investor would focus on Oklo's position as one of the furthest-along advanced reactor companies chasing the AI data center power shortage, noting the roughly $788 million in cash on the balance sheet at the end of 2025 as runway to reach construction milestones. They would want to see those framework agreements with Switch and Meta convert into binding, revenue-generating contracts before treating the growth story as confirmed rather than aspirational.
Investors following Stanley Druckenmiller's approach would view Oklo as a way to play the broader theme of AI-driven electricity demand outrunning the power grid's ability to supply it, rather than as a traditional cash-flow investment. They would watch regulatory catalysts, such as the 2026 approval of Oklo's design criteria report and progress on its license application at Idaho National Laboratory, as the near-term signals that either confirm or unwind the thesis.
A Buffett-style investor would be highly skeptical of Oklo today: the company reported no revenue in any of the last five years, its operating losses widened to about $139 million in 2025 from about $53 million in 2024, and its plan to become a power seller depends on regulatory approvals and a reactor design that has never operated commercially. They would wait for a demonstrated, licensed, cash-generating reactor before considering the stock, since the current price reflects a story rather than a proven business.
Investors who follow Peter Lynch's approach would like that Oklo's business model is simple to explain, build reactors and sell the power, but would be uneasy that the earnings and cash flow do not yet exist to back up the growth story: the company burned about $82 million in operating cash in 2025, more than double the prior year, with capital expenditures ramping to fund construction. They would treat this as a pre-revenue story stock to watch rather than a name to own on today's fundamentals.
These takes are illustrations of well known investing styles applied to this stock. They are informed guesses, not the actual views, statements, or holdings of the people named.
Oklo is hitting real, independently verifiable regulatory and construction milestones toward its first reactor, but the two things that matter most, a completed operating license and paying customers, have not happened yet. The gigawatts of customer demand the company highlights are signed but non-binding framework agreements, not revenue-generating contracts, and the flagship Air Force base project has a history of being paused once before.
Independent, third-party-reported milestones back real progress: Oklo broke ground at the Idaho site in September 2025 with Kiewit as lead constructor, the Department of Energy approved a nuclear safety design agreement, and in May 2026 the NRC approved the plant's principal design criteria topical report on an accelerated schedule. However, the combined license application that must be approved before the reactor can legally operate is still in progress, so the 2027-2028 target remains unproven until the NRC actually grants that license.
Switch's and Meta's own public announcements confirm these deals exist, but both are structured as non-binding master framework agreements rather than signed, binding power purchase contracts, meaning individual projects and firm pricing still need to be negotiated site by site. Oklo's own SEC filings show zero recorded revenue in any year through 2025, consistent with these being future pipeline rather than contracted, paying business today.
The Department of the Air Force and Defense Logistics Agency issued their own public notice of intent to award reaffirming Oklo's selection in June 2025, which is independent confirmation the government picked Oklo. But the underlying contract is still contingent on Oklo first obtaining an NRC license, and a similar award to Oklo for the same base was issued and then rescinded back in 2023, so a signed, binding 30-year contract is not yet in hand.
Based on public evidence such as filings, customer announcements, and delivery records.
Oklo does not sell reactors. Its plan is to build compact fast reactors called Aurora powerhouses, keep ownership of them, and sell the electricity and heat they produce to a customer under a long-term power contract, similar to how a power plant operator sells electricity rather than selling the plant itself. The company has not yet completed a reactor or booked any revenue; its near-term work is regulatory approval, construction, and lining up long-term power deals with data center operators, industrial customers, and government sites.
We'd revisit this call if the price falls below $15.00 or rises above $85.00.
These are review triggers for us to take another look, not price targets or a promise the stock will reach them.
Peer benchmark data not available.
** Oklo is a pre-commercial advanced nuclear company with three lines of business: Aurora Powerhouse (microreactor power generation, pre-revenue), fuel recycling (planned Oak Ridge, TN facility, pre-revenue), and isotopes/specialty manufacturing (Atomic Alchemy, Groves reactor, plus the 2026 ARMEC and Creative Engineers acquisitions). It has no operating power plant and no formal operating segments. Its history has under four years of any revenue or EPS data, which is why the automated screen correctly declined to score it (gate: revenue years=0, eps years=2).
** Q2 2026 revenue was $1.21 million, the company's first ever, versus $0 in Q2 2025 and $0 in Q1 2026, from $800K engineering/consulting, $168K manufacturing/fabrication, and $242K other, tied to the 2026 acquisitions. Q2 2026 net loss was $48.5 million (adjusted EPS -$0.28) versus a $33.1 million net loss in Q1 2026 and a $24.7 million net loss in Q2 2025. First-half 2026 operating loss was $124.2 million, partly offset by $44.5 million of net interest and dividend income (source: Oklo Q2 2026 results, businesswire.com, 2026-08-07).
** Quarterly operating cash flow has moved from -$18.5M (Q2 2025) to -$18.0M (Q3 2025) to -$33.4M (Q4 2025) to -$17.9M (Q1 2026) to -$47.6M (Q2 2026). Capex has accelerated sharply: -$0.9M, -$5.1M, -$27.0M, -$32.8M, -$94.1M over the same five quarters. Trailing-twelve-month free cash flow (Q3 2025 through Q2 2026) is approximately -$276 million, versus a full fiscal-2025 baseline of about -$115 million (OCF -$82.2M, capex $33.2M) in the normalized EDGAR series the automated screen was built from. Full-year 2026 guidance was raised this quarter to $120-150M operating cash use and $400-500M capex, roughly double the prior guide (source: Oklo Q2 2026 results, stockanalysis.com quarterly financials, accessed 2026-08-21).
** Cash and marketable securities were $3.0 billion at June 30, 2026 ($1.6B cash/equivalents, $1.4B marketable securities), up from $2.5 billion at March 31, 2026 and $0.88 billion at December 31, 2025, funded largely by a $1.5 billion at-the-market equity program disclosed December 4-5, 2025 (about 15.8 million shares sold). Shares outstanding rose from 137.7 million (fiscal year-end 2024) to 160.5 million (fiscal year-end 2025) to 186.0 million as of the August 7, 2026 10-Q cover page, roughly 35% growth in 20 months. Total debt is minimal (under $1.5 million in each of the last three years per the normalized series).
** See the Q10 KPI pack in the checklist for the full comparison table (revenue, cash, guidance, share count, pipeline, and regulatory status, each with source and date).
** NuScale Power (SMR) is the closest public peer and remains the only US company with an NRC design-certified SMR; Oklo has not yet received NRC design approval or a final combined license for Aurora. NuScale's near-term path leans on utilities and large power providers, while Oklo is chasing a broader mix of data centers, industrial sites, and government customers (source: Motley Fool, NuScale vs Oklo, 2026-03-06).
** AI data center electricity demand and a supportive federal posture toward advanced nuclear, including DOE's Reactor Pilot Program that fast-tracked the Groves reactor from groundbreaking to first criticality in 11 months, are the main tailwinds. Rate and capital markets conditions matter less directly since Oklo is funding itself with equity, not debt, but a weaker equity market or renewed AI-capex skepticism would directly pressure its ability to keep raising cash cheaply.
** Sam Altman, an early backer and former board chairman, stepped down from the chairman role in April 2025 to avoid a conflict of interest given OpenAI-Oklo commercial discussions; he remains a major shareholder. Public reporting references insider open-market sales in March and July 2026, though specific Form 4 details were not independently itemized here (source: SEC Form 4 filings, referenced via secondary reporting, 2026).
** Catalysts: DOE readiness review/startup approval for Groves; further conversion of letters of intent (Switch, Equinix, Diamondback, Meta) into binding, prepaid contracts; NRC action on the Aurora-INL combined license. Risks: nuclear construction delay and cost-overrun history (Vogtle 3&4 ran about 7 years late and roughly 2x over original budget); continued heavy dilution; guidance already raised twice in 2026 without matching revenue growth; almost all customer pipeline is non-binding.
** Cash-use and capex guidance were both raised in the same quarter the company announced its first revenue, and share count grew about 35% in 20 months, both signs that capital needs are outrunning monetization. Falsification trigger: a public delay to the 2027-2028 Aurora-INL commercial operation target, or a material NRC schedule slip, would undercut the near-term bull case.
** Bear ($15-18): Aurora-INL delays past 2028, pipeline mostly fails to convert, stock re-rates toward net cash plus modest optionality. Base ($35-45): Aurora-INL lands close to the 2027-2028 target, isotopes revenue ramps modestly, low-single-digit GW of the pipeline converts to binding contracts by the early 2030s. Bull ($70-100): accelerated regulatory pace (as shown at Groves) extends to Aurora-INL and other sites, a meaningful share of the 14 GW pipeline becomes binding and prepaid, and Oklo achieves real fleet economics by the early 2030s.
Mechanical model output, a screen, not a fair value.conservative screen, understates growth/AI-capex names
A scenario-weighted valuation (bear/base/bull, driven mainly by whether the Aurora-INL plant reaches commercial operation on the 2027-2028 target and how much of the roughly 14 GW of non-binding customer interest converts into paid, financed contracts) puts fair value at or below the current price. The market already appears to be paying for on-schedule execution and real pipeline conversion despite the company having booked only about one million dollars of total revenue to date.
Research flagged that one or more mechanical-screen inputs look invalid or distorted (e.g. a data-extraction issue or a capex/FCF definition mismatch); the research verdict was independently re-derived from primary filings, not just a check on the same numbers.
Confidence = 0.7 × research sub-score + 0.3 × mechanical sub-score. Mechanical sub-score rewards the Layer 1 screen for agreeing with Layer 2's direction (corroboration), not just for being conviction=NORMAL in isolation.